High seroconversion rate but low antibody titers after two injections of BNT162b2 (Pfizer-BioNTech) vaccine in patients treated by chemotherapy for solid cancers Authors - Sorbonne Université
Journal Articles Annals of Oncology Year : 2021

High seroconversion rate but low antibody titers after two injections of BNT162b2 (Pfizer-BioNTech) vaccine in patients treated by chemotherapy for solid cancers Authors

Z. Adjoutah
  • Function : Author
J. Barrière
  • Function : Author
Fichier principal
Vignette du fichier
Palich et al. - 2021 - High seroconversion rate but low antibody titers a.pdf (280.43 Ko) Télécharger le fichier
Origin Files produced by the author(s)

Dates and versions

hal-03273233 , version 1 (29-06-2021)

Identifiers

Cite

Romain Palich, M. Veyri, A. Vozy, S. Marot, J. Gligorov, et al.. High seroconversion rate but low antibody titers after two injections of BNT162b2 (Pfizer-BioNTech) vaccine in patients treated by chemotherapy for solid cancers Authors. Annals of Oncology, In press, ⟨10.1016/j.annonc.2021.06.018⟩. ⟨hal-03273233⟩
47 View
41 Download

Altmetric

Share

More